Medical Genetics and Genomics · Valhalla, NY
NPI
1831164672
Since 2006
Specialty
Medical Genetics and Genomics
Code 170100000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
100 Woods Rd
Valhalla, NY, 10595
Phone (914) 909-9018
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
82 prescriptions
Company payments, 2025
$110K
From 4 companies
Medicare prescription drug claims, 2024
In 2024, the drug Maryam Banikazemi prescribed most often to Medicare patients was Fabrazyme (Agalsidase Beta), with 48 prescriptions and refills. In total Maryam Banikazemi wrote 82 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fabrazyme Agalsidase Beta | 48 | 48 | Under 11 | $658K |
| Galafold Migalastat Hcl | 18 | 18 | Under 11 | $531K |
Brand drugs: 66 claims; generic drugs: 16 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maryam Banikazemi $110K ($110K in general payments such as food, travel and fees) from 4 companies. The largest payer was Genzyme Corporation with $110K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 55 | $110K |
| Chiesi USA, Inc. | 2 | $398 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.